Dr. Andrew C. Breiterman, MD

Dr. Breiterman practices at South Coast Global Medical Center in Santa Ana, California, part of KPC Group.

Dr. Breiterman's NPI, 1770766479, was assigned on December 17, 2007. Dr. Breiterman graduated from Rutgers New Jersey Medical School in 1983. Dr. Breiterman holds California license G54442.

Dr. Breiterman's primary practice is South Coast Global Medical Center, at 2701 S Bristol St, Santa Ana, CA 92704 in Orange County. The practice phone is (714) 754-5454.

Dr. Breiterman's primary practice is South Coast Global Medical Center in Santa Ana, California, part of KPC Group. Dr. Breiterman is also affiliated with Providence Mission Hospital. The medical group on file is Reza Shahbaz, M.D., Inc. Dmand AI also links Dr. Breiterman to 4 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Breiterman practices, 6 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Breiterman's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Breiterman is board certified in diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Breiterman's licenses on file in 3 states: California, Guam and Florida.

CMS data shows 7,483 Medicare services from Dr. Breiterman across 65 procedure codes in 2024, for 2,784 Medicare patients. Medicare paid $149,352 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 2,784 Medicare patients who saw Dr. Breiterman in 2024. The largest group is 65 to 74, with 989 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 87% are also on Medicaid. Their average risk score is 3.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Breiterman's median patient age at 57, with 51% women.

In 2019, Dr. Breiterman wrote 15 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $82 in total drug cost. In 2018, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Breiterman for performance year 2024, reported as part of a group. Dr. Breiterman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Dr. Breiterman from 6 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $466.

Dr. Breiterman graduated from Rutgers New Jersey Medical School in 1983.

Dr. Breiterman is in network with 5 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.